Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study-Reference-Cited by-同舟云学术

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study

Published:2014-02-04 Issue:2 Volume:9 Page:e84676
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Echeverría Patricia,Bonjoch Anna,Puig Jordi,Moltó José,Paredes Roger,Sirera Guillem,Ornelas Arelly,Pérez-Álvarez Nuria,Clotet Bonaventura,Negredo Eugènia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Antiretroviral treatment of adult HIV infection. 2012 recommendations of the International AIDS Society-USA panel;M Thompson;JAMA,2012

2. US Department for Health and Social Security (2011) Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents, January 10th 2011.http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?GuidelineID=7. Accessed March 2011.

3. European AIDS Clinical Society (EACS) (2011) Guidelines for the clinical management of HIV infected adults in Europe. http://www.europeanaidsclinicalsociety.org/guidelinespdf/1_Treatment_of_HIV_Infected_Adults.pdf Last accessed: May 2011.

4. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial;JV Madruga;Lancet,2007

5. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial;A Lazzarin;Lancet,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

2. Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat;Biomedicines;2021-03-18

3. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16

4. Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV;Pharmaceuticals;2020-06-11

5. Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review;Clinical Pharmacokinetics;2019-11-02